Introduction
We experienced a case of severe neonatal exanthematous disease accompanied with septicemia caused by methicillin-resistant Staphylococcus aureus (MRSA), whichwas a producer of Toxic Shock Syndrome Toxin-1 (TSST-1). The feature of eruption in this case was unique and the clinical course resembled Toxic Shock Syndrome (TSS). TSS is a rare condition with few confirmed occurrences in infancy . In the neonatal period the criteria of TSS have never been validated1).
Recently a new concept of neonatal MRSA infection was reported and the authors proposed the name of "neonatal TSS-like exanthematous disease"(NTED)2).
In the following context we would like to emphasize that this patient had a severe case of NTED and we must pay attention to this disease. coagulation. Antibiotic treatment was changed from cephalothin to vancomycin (45mg/kg per day), and anticoagulant therapy was also started. On the 6th hospital day, generalized desquamation of the skin started at the feet and hands. The general condition then improved slowly. The patient recovered from the illness without any sequelae and was discharged on the 28 th hospital day. The presented case was a neonate and the isolated MRSA strains produced TSST-1. However, the clinical features including diffuse subpapular erythema with many pustules on the skin surface over the whole body were different from NTED. We speculated that if a large amount of TSST-1were released into the blood, even though the patient was a neonate who had immature immunity, the cytokines would induce serious signs and symptoms that we have observed. Thus, whenwe treat any neonatal exanthematous disease, we should take blood cultures and pay close attention to the clinical course.
